Evaluation of Nano-Zinc Borate Effects on Thermal Properties, Morphology, Antibacterial Activity, and Drug Release Behavior of Starch/Gelatin Hydrogel Films for Biomedical Applications
Özet
Starch and gelatin offer opportunities for use due to their non-toxicity, biocompatibility, physical and functional properties. In this study, different amounts of nano-zinc borate were added to starch/gelatin composition for biological applications and their properties were studied. The structure of the films was investigated by various techniques. Nanostructured zinc borate was synthesized using a chemical method and particle sizes were determined as 196 nm. The atenolol drug was doped into the polymer composite. The atenolol release was performed at pH 7.4 and in phosphate-buffered saline solution medium. Cumulative drug release was 76% with the inclusion of nano-zinc borate in the polymer mixture. The atenolol release was approximately 50%–70% in films with nano-zinc borate added after 300 min. Furthermore, thermal resistance of the films improved with the addition of nano-zinc borate. The investigated chemical compound exhibited pronounced antibacterial activity against Gram-positive bacteria (Bacillus subtilis and Staphylococcus aureus), with significantly greater potency compared to Gram-negative bacteria (E. coli and Pseudomonas aeruginosa). Notably, the formulation containing 1.5% starch, 0.5% gelatin, and 1% nano-zinc borate demonstrated broad-spectrum efficacy against all tested pathogens, highlighting its potential as a promising antibacterial agent. The observed differential activity against bacterial strains suggests that fine-tuning the concentrations of starch, gelatin, and nano-zinc borate may optimize antibacterial efficacy and broaden the spectrum. The results showed us that non-toxic and biocompatible polymer films can be realized in pharmaceutical industry systems and biomedical applications.
Anahtar Kelimeler
- Scopus
- 0
- WoS
- 0
- OpenAlex
- 0
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Koçak, Berna | |
| dc.contributor.author | Gürler, Nedim | |
| dc.contributor.author | İpek, Yeliz | |
| dc.contributor.author | Yazdıç, Ferit Can | |
| dc.contributor.author | Karaman, Altuğ | |
| dc.date.accessioned | 2026-10-28T14:54:09.804368852Z | |
| dc.date.available | 2026-10-28T14:54:09.804368852Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | Starch and gelatin offer opportunities for use due to their non-toxicity, biocompatibility, physical and functional properties. In this study, different amounts of nano-zinc borate were added to starch/gelatin composition for biological applications and their properties were studied. The structure of the films was investigated by various techniques. Nanostructured zinc borate was synthesized using a chemical method and particle sizes were determined as 196 nm. The atenolol drug was doped into the polymer composite. The atenolol release was performed at pH 7.4 and in phosphate-buffered saline solution medium. Cumulative drug release was 76% with the inclusion of nano-zinc borate in the polymer mixture. The atenolol release was approximately 50%–70% in films with nano-zinc borate added after 300 min. Furthermore, thermal resistance of the films improved with the addition of nano-zinc borate. The investigated chemical compound exhibited pronounced antibacterial activity against Gram-positive bacteria (Bacillus subtilis and Staphylococcus aureus), with significantly greater potency compared to Gram-negative bacteria (E. coli and Pseudomonas aeruginosa). Notably, the formulation containing 1.5% starch, 0.5% gelatin, and 1% nano-zinc borate demonstrated broad-spectrum efficacy against all tested pathogens, highlighting its potential as a promising antibacterial agent. The observed differential activity against bacterial strains suggests that fine-tuning the concentrations of starch, gelatin, and nano-zinc borate may optimize antibacterial efficacy and broaden the spectrum. The results showed us that non-toxic and biocompatible polymer films can be realized in pharmaceutical industry systems and biomedical applications. | |
| dc.identifier.articlenumber | e57623 | |
| dc.identifier.doi | 10.1002/app.57623 | |
| dc.identifier.eissn | 1097-4628 | |
| dc.identifier.issn | 0021-8995 | |
| dc.identifier.issue | 42 | |
| dc.identifier.scopus | 2-s2.0-105010655880 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/munzur/1398 | |
| dc.identifier.volume | 142 | |
| dc.identifier.wos | WOS:001525751300001 | |
| dc.language.iso | en | |
| dc.publisher | John Wiley and Sons Inc | |
| dc.relation.ispartof | Journal of Applied Polymer Science | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | biodegradable polymer(s) | |
| dc.subject | biopharmaceutical characterization | |
| dc.subject | drug release | |
| dc.subject | nano-zinc borate | |
| dc.subject.classification | Polymer Science | |
| dc.subject.other | Bacteriology | |
| dc.subject.other | Biocompatibility | |
| dc.subject.other | Borate minerals | |
| dc.subject.other | Controlled drug delivery | |
| dc.subject.other | Drug products | |
| dc.subject.other | Escherichia coli | |
| dc.subject.other | Morphology | |
| dc.subject.other | Staphylococcus aureus | |
| dc.subject.other | Targeted drug delivery | |
| dc.subject.other | Zinc compounds | |
| dc.subject.other | Anti-bacterial activity | |
| dc.subject.other | Atenolol | |
| dc.subject.other | Biodegradable polymer(s) | |
| dc.subject.other | Biopharmaceutical characterization | |
| dc.subject.other | Biopharmaceuticals | |
| dc.subject.other | Drug release | |
| dc.subject.other | Nano-zinc borate | |
| dc.subject.other | Property | |
| dc.subject.other | Thermal | |
| dc.subject.other | Zinc borate | |
| dc.subject.other | Medical applications | |
| dc.subject.other | Starch | |
| dc.title | Evaluation of Nano-Zinc Borate Effects on Thermal Properties, Morphology, Antibacterial Activity, and Drug Release Behavior of Starch/Gelatin Hydrogel Films for Biomedical Applications | |
| dc.type | Article | |
| rdl.citation.openalex | 0 | |
| rdl.citation.scopus | 0 | |
| rdl.citation.wos | 0 | |
| rdl.oa.status | closed | |
| rdl.scopus.quartile | Q2 | |
| rdl.sdg | SDG03 | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.wos.index | Science Citation Index Expanded (SCI-EXPANDED) |

